Q1 2017

Filed May 15, 2017 · 10-Q · 45 days after period end · 0001477932-17-002213

Q1 2017 · 10-Q

Revenue

$134.23K

−41.7% vs Q1 2016

Net Income

-$38.34M

N/M vs Q1 2016

EPS Diluted

-$0.19

— vs Q1 2016

Operating Income-$412,343N/M

Operating Cash Flow

Same quarter

Metric	Q1 2017	Q1 2016	Q1 2015	Q1 2014
Revenue	$134.23K	$230.41K	$275.47K	$130.83K
Net Income	-$38.34M	-$528.59K	-$203.17K	-$1.08M
EPS Diluted	-$0.19	$0.00	$0.00	-$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR